Cite
HARVARD Citation
Toor, S. et al. (2019). Effect of pembrolizumab on CD4+CD25+, CD4+LAP+ and CD4+TIM‐3+ T cell subsets. Clinical and experimental immunology. pp. 345-352. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toor, S. et al. (2019). Effect of pembrolizumab on CD4+CD25+, CD4+LAP+ and CD4+TIM‐3+ T cell subsets. Clinical and experimental immunology. pp. 345-352. [Online].